Effects of a single dose of erythropoietin on subsequent seizure susceptibility in rats exposed to acute hypoxia at P10

Epilepsia

Volumn 48, Issue 1, 2007, Pages 175-181

  Mikati, Mohamad A ^a   Hokayem, Jimmy A El ^a   Sabban, Marwan E El ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Erythropoietin; Neonatal hypoxia; Neuronal apoptosis; Seizure susceptibility; Status Epilepticus

Indexed keywords

ERYTHROPOIETIN; KAINIC ACID; NEUROPROTECTIVE AGENT; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL COUNT; CELL LOSS; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; HIPPOCAMPUS; HYPOXIA; NERVE CELL LESION; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE SUSCEPTIBILITY; SINGLE DRUG DOSE; VIDEOTAPE;

ANIMALS; ANIMALS, NEWBORN; ANOXIA; CELL COUNT; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN; EXCITATORY AMINO ACID AGONISTS; HIPPOCAMPUS; HUMANS; HYPOXIA, BRAIN; KAINIC ACID; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES;

EID: 33846247068     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2006.00900.x     Document Type: Article

References (64)

1. Beccari M. (1994) Seizures in dialysis patients treated with recombinant erythropoietin. Review of the literature and guidelines for prevention. International Journal of Artificial Organs 17:5-13.
2. Beccari M, Romagnoni M, Sorgato G. (1995) Seizures in dialysis patients treated with recombinant erythropoietin. Nephrology Dialysis Transplantation 10:423-424.
3. Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET, Petit E. (1999) A potential role for erythropoietin in focal permanent cerebral ischemia in mice. Journal of Cerebral Blood Flow and Metabolism 19:643-651.
4. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857-868.
5. Campana WM, Misasi R, O'Brien JS. (1998) Identification of a neurotrophic sequence in erythropoietin. International Journal of Molecular Medicine 1:235-241.
6. Casadevall N, Nataf J, Viron B, Kolta A, Kiladjian JJ, Martin-Dupont P, Michaud P, Papo T, Ugo V, Teyssandier I, Varet B, Mayeux P. (2002) Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. New England Journal of Medicine 346:469-475.
7. Chong ZZ, Kang JQ, Maiese K. (2002a) Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation 106:2973-2979.
8. Chong ZZ, Kang JQ, Maiese K. (2002b) Angiogenesis and plasticity: role of erythropoietin in vascular systems. Journal of Hematotherapeutic Stem Cell Research 11:863-871.
9. Chong ZZ, Kang JQ, Maiese K. (2003a) Erythropoietin: cytoprotection in vascular and neuronal cells. Current Drug Targets Cardiovascular and Haematological Disorders 3:141-154.
10. Chong ZZ, Kang JQ, Maiese K. (2003b) Apaf-1, Bcl-xL, cytochrome c, and caspase-9 form the critical elements for cerebral vascular protection by erythropoietin. Journal of Cerebral Blood Flow and Metabolism 23:320-330.
11. Chong ZZ, Kang JQ, Maiese K. (2003c) Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways. British Journal of Pharmacology 138:1107-1118.
12. Chong ZZ, Lin SH, Kang JQ, Maiese K. (2003d) Erythropoietin prevents early and late neuronal demise through modulation of AKt1 and induction of caspace 1, 3, and 8. Journal of Neuroscience Research 71:659-669.
13. Chong ZZ, Lin SH, Maiese K. (2004) The NAD+ precursor nicotinamide governs neuronal survival during oxidative stress through protein kinase B coupled to FOXO3a and mitochondrial membrane potential. Journal of Cerebral Blood Flow and Metabolism 24:728-743.
14. Chong ZZ, Maiese K. (2004) Targeting WNT, protein kinase B, and mitochondrial membrane integrity to foster cellular survival in the nervous system. Histology and Histopathology 19:495-504.
15. Dell'Anna ME, Calzolari S, Molinari M, Iuvone L, Calimici R. (1991) Neonatal anoxia induces transitory hyperactivity, permanent spatial memory deficits and CA1 cell density reduction in developing rats. Behavioral Brain Research 45:125-134.
16. Demers EJ, McPherson RJ, Juul SE. (2005) Erythropoietin protects dopaminergic neurons and improves neurobehavioral outcomes in juvenile rats after neonatal hypoxia-ischemia. Pediatric Research 58:297-301.
17. Diaz Z, Assaraf MI, Miller WH Jr., Schipper HM. (2005) Astroglial cytoprotection by erythropoietin pre-conditioning: implications for ischemic and degenerative CNS disorders. Journal of Neurochemistry 93:392-402.
18. Digicaylioglu M, Lipton SA. (2001) Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412:641-647.
19. Dzietko M, Felderhoff-Mueser U, Sifringer M, Krutz B, Bittigau P, Thor F, Heumann R, Buhrer C, Ikonomidou C, Hansen HH. (2004) Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity. Neurobiology of Disease 15:177-187.
20. Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, Rustenbeck HH, Breiter N, Jacob S, Knerlich F, Bohn M, Poser W, Ruther E, Kochen M, Gefeller O, Gleiter C, Wessel TC, De Ryck M, Itri L, Prange H, Cerami A, Brines M, Siren AL. (2002) Erythropoietin therapy for acute stroke is both safe and beneficial. Molecular Medicine 8:495-505.
21. Ehrenreich H, Degner D, Meller J, Brines M, Behe M, Hasselblatt M, Woldt H, Falkai P, Knerlich F, Jacob S, von Ahsen N, Maier W, Bruck W, Ruther E, Cerami A, Becker W, Siren AL. (2004) Erythropoietin: a candidate compound for neuroprotection in schizophrenia. Molecular Psychiatry 9:42-54.
22. Figueroa YG, Chan AK, Ibrahim R, Tang Y, Burow ME, Alam J, Scandurro AB, Beckman BS. (2002) NF-kappaB plays a key role in hypoxia-inducible factor-1-regulated erythropoietin gene expression. Experimental Hematology 30:1419-1427.
23. Genc S, Koroglu TF, Genc K. (2004) Erythropoietin as a novel neuroprotectant. Restorative Neurology and Neuroscience 22:105-119.
24. Gil JM, Leist M, Popovic N, Brundin P, Petersen A. (2004) Asialoerythropoietin is not effective in the R6/2 line of Huntington's disease mice. BMC Neuroscience 5:17.
25. Grasso G, Buemi M, Alafaci C, Sfacteria A, Passalacqua M, Sturiale A, Calapai G, De Vico G, Piedimonte G, Salpietro FM, Tomasello F. (2002) Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage. Proceedings of the National Academy of Sciences U.S.A. 99:5627-5631.
26. Heidbreder M, Frohlich F, Johren O, Dendorfer A, Qadri F, Dominiak P. (2003) Hypoxia rapidly activates HIF-3alpha mRNA expression. Federation of American Societies for Experimental Biology Journal 17:1541-1543.
27. Henry DH, Bowers P, Romano MT, Provenzano R. (2004) Epoetin alfa. Clinical evolution of a pleiotropic cytokine. Archives of Internal Medicine 164:262-276.
28. Huang YF, Zhuang SQ, Chen DP, Liang YJ, Li XY. (2004) [Angiogenesis and its regulatory factors in brain tissue of neonatal rat hypoxic-ischemic encephalopathy]. Zhonghua Er Ke Za Zhi 42:210-214.
29. Jelkmann W. (1992) Erythropoietin: structure, control of production, and function. Physiological Reviews 72:449-489.
30. Jensen FE, Applegate CD, Holtzman D, Belin TR, Burchfiel JL. (1991) Epileptogenic effect of hypoxia in the immature rodent brain. Annals of Neurology 29:629-637.
31. Jensen FE, Holmes GL, Lombroso CT, Blume HK, Firkusny IR. (1992) Age-dependent changes in long-term seizure susceptibility and behavior after hypoxia in rats. Epilepsia 33:971-980.
32. Jensen FE, Wang C, Stafstrom CE, Liu Z, Geary C, Stevens MC. (1998) Acute and chronic increases in excitability in rat hippocampal slices after perinatal hypoxia In vivo. Journal of Neurophysiology 79:73-81.
33. Juul S. (2002) Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage. Acta Paediatrica Supplement 91:36-42.
34. Kang JQ, Chong ZZ, Maiese K. (2003a) Akt1 protects against inflammatory microglial activation through maintenance of membrane asymmetry and modulation of cysteine protease activity. Journal of Neuroscience Research 74:37-51.
35. Kang JQ, Chong ZZ, Maiese K. (2003b) Critical role for Akt1 in the modulation of apoptotic phosphatidylserine exposure and microglial activation. Molecular Pharmacology 64:557-569.
36. Kawakami M, Sekiguchi M, Sato K, Kozaki S, Takahashi M. (2001) Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. Journal of Biological Chemistry 276:39469-39475.
37. Kerendi F, Halkos ME, Kin H, Corvera JS, Brat DJ, Wagner MB, Vinten-Johansen J, Zhao ZQ, Forbess JM, Kanter KR, Kelley ME, Kirshbom PM. (2005) Upregulation of hypoxia inducible factor is associated with attenuation of neuronal injury in neonatal piglets undergoing deep hypothermic circulatory arrest. Journal of Thoracic and Cardiovascular Surgery 130:1079.
38. Koh S, Jensen FE. (2001) Topiramate blocks perinatal hypoxia-induced seizures in rat pups. Annals of Neurology 50:366-372.
39. Koh S, Tibayan FD, Simpson JN, Jensen FE. (2004) NBQX or topiramate treatment after perinatal hypoxia-induced seizures prevents later increases in seizure-induced neuronal injury. Epilepsia 45:569-575.
40. Kumral A, Uysal N, Tugyan K, Sonmez A, Yilmaz O, Gokmen N, Kiray M, Genc S, Duman N, Koroglu TF, Ozkan H, Genc K. (2004) Erythropoietin improves long-term spatial memory deficits and brain injury following neonatal hypoxia-ischemia in rats. Behavioral Brain Research 153:77-86.
41. Kumral A, Genc S, Ozer E, Yilmaz O, Gokmen N, Koroglu TF, Duman N, Genc K, Ozkan H. (2006) Erythropoietin downregulates bax and DP5 preapoptotic gene expression in neonatal hypoxic-ischemic brain injury. Biology of the Neonate 89:205-210.
42. Legido A, Clancy RR, Berman PH. (1991) Neurologic outcome after electroencephalographically proven neonatal seizures. Pediatrics 88:583-596.
43. Leist M, Ghezzi P, Grasso G, Bianchi R, Villa P, Fratelli M, Savino C, Bianchi M, Nielsen J, Gerwien J, Kallunki P, Larsen AK, Helboe L, Christensen S, Pedersen LO, Nielsen M, Torup L, Sager T, Sfacteria A, Erbayraktar S, Erbayraktar Z, Gokmen N, Yilmaz O, Cerami-Hand C, Xie QW, Coleman T, Cerami A, Brines M. (2004) Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305:239-242.
44. Mahmud DLMGA, Deb DK, Platanias LC, Uddin S, Wickrema A. (2002) Phosphorylation of forkhead transcription factors by erythropoietin and stem cell factor prevents acetylation and their interaction with coactivator p300 in erythroid progenitor cells. Oncogene 21:1556-1562.
45. Maiese K, Li F, Chong ZZ. (2004) Erythropoietin in the brain: can the promise to protect be fulfilled? Trends in Pharmacological Sciences 25:577-583.
46. Marti HH. (2004) Erythropoietin and the hypoxic brain. Journal of Experimental Biology 207:3233-3242.
47. Matsushita H, Johnston MV, Lange MS, Wilson MA. (2003) Protective effect of erythropoietin in neonatal hypoxic ischemia in mice. Neuroreport 14:1757-1761.
48. Mikati MA, Abi-Habib RJ, El Sabban ME, Dbaibo GS, Kurdi RM, Kobeissi M, Farhat F, Asaad W. (2003) Hippocampal programmed cell death after status epilepticus: evidence for NMDA-receptor and ceramide-mediated mechanisms. Epilepsia 44:282-291.
49. Mikati MA, Holmes GL, Werner S, Bakkar N, Carmant L, Liu Z, Stafstrom CE. (2004a) Effects of nimodipine on the behavioral sequalae of experimental status epilepticus in prepubescent rats. Epilepsy and Behavior 5:168-174.
50. Mikati MA, Kurdit RM, Rahmeh AA, Farhat F, Abu Rialy S, Lteif L, Francis E, Geha G, Maraashli W. (2004b) Effects of creatine and cyclocreatine supplementation on kainate induced injury in prepubescent rats. Brain Injury 18:1229-1241.
51. Mikati MA, Zeinieh MP, Kurdi RM, Harb SA, El Hokayem JA, Daderian RH, Shamseddine A, Obeid M, Bitar FF, El Sabban M. (2005) Long-term effects of acute and of chronic hypoxia on behavior and on hippocampal histology in the developing brain. Brain Research Developmental Brain Research 157:98-102.
52. Miyashita K, Tojo A, Kimura K, Goto A, Omata M, Nishiyama K, Fujita T. (2004) Blood pressure response to erythropoietin injection in hemodialysis and predialysis patients. Hypertension Research 27:79-84.
53. Olsen NV. (2003) Central nervous system frontiers for the use of erythropoietin. Clinical Infectious Diseases 37(suppl 4):S323-330.
54. Raab S, Beck H, Gaumann A, Yuce A, Gerber HP, Plate K, Hammes HP, Ferrara N, Breier G. (2004) Impaired brain angiogenesis and neuronal apoptosis induced by conditional homozygous inactivation of vascular endothelial growth factor. Thrombosis and Haemostasis 91:595-605.
55. Shingo T, Sorokan ST, Shimazaki T, Weiss S. (2001) Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neuroscience 21:9733-9743.
56. Somervaille TC, Linch DC, Khwaja A. (2001) Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax. Blood 98:1374-1381.
57. Spandou E, Papadopoulou Z, Soubasi V, Karkavelas G, Simeonidou C, Pazaiti A, Guiba-Tziampiri O. (2005) Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats. Brain Research 1045:22-30.
58. Vairano M, Dello Russo C, Pozzoli G, Battaglia A, Scambia G, Tringali G, Aloe-Spiriti MA, Preziosi P, Navarra P. (2002) Erythropoietin exerts anti-apoptotic effects on rat microglial cells in vitro. European Journal of Neuroscience 16:584-592.
59. Verdier F, Walrafen P, Hubert N, Chretien S, Gisselbrecht S, Lacombe C, Mayeux P. (2000) Proteasomes regulate the duration of erythropoietin receptor activation by controlling down-regulation of cell surface receptors. Journal of Biological Chemistry 275:18375-18381.
60. Volpe J. (2000) Neurology of the newborn. WB Saunders, Philadelphia.
61. Wang L, Zhang Z, Wang Y, Zhang R, Chopp M. (2004) Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 35:1732-1737.
62. Weishaupt JH, Rohde G, Polking E, Siren AL, Ehrenreich H, Bahr M. (2004) Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells. Investigative Ophthalmology and Visual Science 45:1514-1522.
63. Wiessner C, Allegrini PR, Ekatodramis D, Jewell UR, Stallmach T, Gassmann M. (2001) Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin. Journal of Cerebral Blood Flow and Metabolism 21:857-864.
64. Zhou H, Li XM, Meinkoth J, Pittman RN. (2000) Akt regulates cell survival and apoptosis at a postmitochondrial level. Journal of Cell Biology 151:483-494.